share_log

Goldman Sachs Initiates Coverage On Vaxcyte With Buy Rating, Announces Price Target of $135

Goldman Sachs Initiates Coverage On Vaxcyte With Buy Rating, Announces Price Target of $135

高盛对Vaxcyte启动了覆盖,并给予买入评级,宣布目标价为135美元。
Benzinga ·  12/20 20:51  · 评级/大行评级

Goldman Sachs analyst Chris Shibutani initiates coverage on Vaxcyte (NASDAQ:PCVX) with a Buy rating and announces Price Target of $135.

高盛分析师Chris Shibutani对Vaxcyte(纳斯达克:PCVX)启动覆盖,给予买入评级,并宣布目标价格为135美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发